Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4.

Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Abstract Text:

    hyung s younHyung S Youn,joo y leeJoo Y Lee,shin i saitohShin I Saitoh,kensuke miyakeKensuke Miyake,daniel h hwangDaniel H Hwang,

    Toll-like receptors (TLRs), which are activated by invading microorganisms or endogenous molecules, evoke immune and inflammatory responses. TLR activation is closely linked to the development of many chronic inflammatory diseases including rheumatoid arthritis. Auranofin, an Au(I) compound, is a well-known and long-used anti-rheumatic drug. However, the mechanism as to how auranofin relieves the symptom of rheumatoid arthritis has not been fully clarified. Our results demonstrated that auranofin suppressed TLR4-mediated activation of transcription factors, NF-kappaB and IRF3, and expression of COX-2, a pro-inflammatory enzyme. This suppression was well correlated with the inhibitory effect of auranofin on the homodimerization of TLR4 induced by an agonist. Furthermore, auranofin inhibited NF-kappaB activation induced by MyD88-dependent downstream signaling components of TLR4, MyD88, IKKbeta, and p65. IRF3 activation induced by MyD88-independent signaling components, TRIF and TBK1, was also downregulated by auranofin. Our results first demonstrate that auranofin suppresses the multiple steps in TLR4 signaling, especially the homodimerization of TLR4. The results suggest that the suppression of TLR4 activity by auranofin may be the molecular mechanism through which auranofin exerts anti-rheumatic activity.

    Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Publishing Authors By Initials

    hs younHS Youn,jy leeJY Lee,si saitohSI Saitoh,k miyakeK Miyake,dh hwangDH Hwang,

    For similar proteins: membrane proteins: receptors, cell surface: receptors, immunologic: receptors, pattern recognition: toll-like receptors: toll-like receptor 4 research abstracts see: proteins: membrane proteins: receptors, cell surface: receptors, immunologic: receptors, pattern recognition: toll-like receptors: toll-like receptor 4 research

    PUBMED ID PMID:

    MEDLINE DATE:

    Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Biochemical and biophysical research communication

    VOLUME: 350

    Page Numbers: 866-71

    Journal Abbreviation: Biochem. Biophys. Res. Commun.

    ISSN: 0006-291X

    DAY: 28

    MONTH: 09

    YEAR: 2006

    Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 372516

    Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Keywords Mesh Terms:

    KEYWORDS: Toll-Like Receptor 4

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4. Information

    Substance Name: Gold

    Registry Number: 7440-57-5

    Grant and Affiliation Information for Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4.

    AFFILIATION: USDA, ARS, Western Human Nutrition Research Center, Department of Nutrition, University of California, Davis, CA 95616, USA. hyoun@suv.ac.kr

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: DK41868

    ACRONYM: DK

    MEDLINETA: Biochem Biophys Res Commun

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4 Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News